stdClass Object
(
    [id] => 14407
    [paper_index] => 202411-02-019192
    [title] => OVERVIEW OF CLINICAL TRIALS FOR NEW DRUG SAFETY AND EFFICACY
    [description] => 
    [author] => Mr. Avinash D. Hatkar, Mr. Shrikant Rushindar Katkade, Ms. Pooja Mule, Dr. Sunil Jaybhaye, Mr. Saurabh Bondre
    [googlescholar] => 
    [doi] => 
    [year] => 2024
    [month] => November
    [volume] => 9
    [issue] => 11
    [file] => fm/jpanel/upload/2024/November/202411-02-019192.pdf
    [abstract] => Clinical trials is a testing research of a new drug safety and efficacy. Pre-clinical studies starts before clinical trials. In pre-clinical trial may look at whether a drug is safe or the side effects it causes; later trials aim to test whether a new treatment is better than existing treatment. 
Clinical trials study on different phases that are phase 0, 1,2,3,4. Main purpose of phase 0 to help speed up and streamline the drug 
approved the process. In phase 1 trials to find out about closes and side effects. A phase 2 clinical trial is to evaluate the effectiveness 
and safety of a new drug or drug combination for a particular indication. Then in phase 3 study that tests the safety and how well a new treatment works compared with a standard treatment. The main objective of phase 4 trials is to check the drug's performance in real life scenarios. The Phase 4 studies include all studies performed after drug approved and related to the approved indication

    [keywords] => 
    [doj] => 2024-11-28
    [hit] => 
    [status] => 
    [award_status] => P
    [orderr] => 86
    [journal_id] => 2
    [googlesearch_link] => 
    [edit_on] => 
    [is_status] => 1
    [journalname] => EPRA International Journal of Research & Development (IJRD)
    [short_code] => IJSR
    [eissn] =>  2455-7838 (Online)
    [pissn] => - -
    [home_page_wrapper] => images/products_image/2-n.png
)
Error fetching PDF file.